Biomolecules & Therapeutics

The Korean Society of Applied Pharmacology (한국응용약물학회)
권호 표지
DOI QR코드

DOI QR Code

Intravenous Administration of Substance P Attenuates Mechanical Allodynia Following Nerve Injury by Regulating Neuropathic Pain-Related Factors

  • Chung, Eunkyung (BIO R&D Center, L&K BIOMED CO., LTD.) ;
  • Yoon, Tae Gyoon (Department of Anesthesiology and Pain Medicine, Konkuk University Medical Center, Research Institute of Medical Science, Konkuk University School of Medicine) ;
  • Kim, Sumin (Department of Genetic Engineering, College of Life Science and Graduate School of Biotechnology, Kyung Hee University) ;
  • Kang, Moonkyu (Department of Dental Anesthesiology and Dental Research Institute, School of Dentistry, Seoul National University) ;
  • Kim, Hyun Jeong (Department of Dental Anesthesiology and Dental Research Institute, School of Dentistry, Seoul National University) ;
  • Son, Youngsook (Department of Genetic Engineering, College of Life Science and Graduate School of Biotechnology, Kyung Hee University)
  • Received : 2016.06.23
  • Accepted : 2016.10.13
  • Published : 2017.05.01
Download PDF
⟨ Previous Next ⟩

Abstract

This study aimed to investigate the analgesic effect of substance P (SP) in an animal model of neuropathic pain. An experimental model of neuropathic pain, the chronic constriction injury (CCI) model, was established using ICR mice. An intravenous (i.v.) injection of SP (1 nmole/kg) was administered to the mice to examine the analgesic effects of systemic SP on neuropathic pain. Behavioral testing and immunostaining was performed following treatment of the CCI model with SP. SP attenuated mechanical allodynia in a time-dependent manner, beginning at 1 h following administration, peaking at 1 day post-injection, and decaying by 3 days post-injection. The second injection of SP also increased the threshold of mechanical allodynia, with the effects peaking on day 1 and decaying by day 3. A reduction in phospho-ERK and glial fibrillary acidic protein (GFAP) accompanied the attenuation of mechanical allodynia. We have shown for the first time that i.v. administration of substance P attenuated mechanical allodynia in the maintenance phase of neuropathic pain using von Frey's test, and simultaneously reduced levels of phospho-ERK and GFAP, which are representative biochemical markers of neuropathic pain. Importantly, glial cells in the dorsal horn of the spinal cord (L4-L5) of SP-treated CCI mice, expressed the anti-inflammatory cytokine, IL-10, which was not seen in vehicle saline-treated mice. Thus, i.v. administration of substance P may be beneficial for improving the treatment of patients with neuropathic pain, since it decreases the activity of nociceptive factors and increases the expression of anti-nociceptive factors.

Keywords

References

  1. Andoh, T., Nagasawa, T., Satoh, M. and Kuraishi, Y. (1998) Substance P induction of itch-associated response mediated by cutaneous NK1 tachykinin receptors in mice. J. Pharmacol. Exp. Ther. 286, 1140-1145.
  2. Austin, P. J. and Moalem-Taylor, G. (2010) The neuro-immune balance in neuropathic pain: involvement of inflammatory immune cells, immune-like glial cells and cytokines. J. Neuroimmunol. 229, 26-50. https://doi.org/10.1016/j.jneuroim.2010.08.013
  3. Bradesi, S. (2010) Role of spinal cord glia in the central processing of peripheral pain perception. Neurogastroenterol. Motil. 22, 499-511. https://doi.org/10.1111/j.1365-2982.2010.01491.x
  4. Chen, W. L., Zhang, Y. Q. and Zhao, Z. Q. (2006) Neurokinin-1 receptor in peripheral nerve terminals mediates thermal hyperalgesia. Biochem. Biophys. Res. Commun. 339, 132-136. https://doi.org/10.1016/j.bbrc.2005.11.030
  5. Dong, X. G. and Yu, L. C. (2005) Alterations in the substance P-induced anti-nociception in the central nervous system of rats after morphine tolerance. Neurosci. Lett. 381, 47-50. https://doi.org/10.1016/j.neulet.2005.01.084
  6. Gao, Y. J., Zhang, Y. Q. and Zhao, J. Q. (2003) Involvement of spinal neurokinin-1 receptors in the maintenance but not induction of carrageenan-induced thermal hyperalgesia in the rat. Brain Res. Bull. 61, 587-593. https://doi.org/10.1016/S0361-9230(03)00215-6
  7. Gao, Y. J. and Ji, R. R. (2010) Targeting astrocyte signaling for chronic pain. Neurotherapeutics 7, 482-493. https://doi.org/10.1016/j.nurt.2010.05.016
  8. Holden, J. E., Pizzi, J. A. and Jeong, Y. (2009) An NK1 receptor antagonist microinjected into the periaqueductal gray blocks lateral hypothalamic-induced antinociception in rats. Neurosci. Lett. 453, 115-119. https://doi.org/10.1016/j.neulet.2009.01.083
  9. Hong, H. S., Lee, J., Lee, E., Kwon, Y. S., Lee, E., Ahn, W., Jiang, M. H., Kim, J. C. and Son, Y. (2009) A new role of substance P as an injury-inducible messenger for mobilization of $CD29^+$ stromal-like cells. Nat. Med. 15, 425-435. https://doi.org/10.1038/nm.1909
  10. Ji, F. T., Liang, J. J., Liu, L., Cao, M. H. and Li, F. (2013) Curcumin exerts antinociceptive effects by inhibiting the activation of astrocytes in spinal dorsal horn and the intracellular extracellular signal-regulated kinase signaling pathway in rat model of chronic constriction injury. Chin. Med. J 126, 1125-1131.
  11. Jiang, M. H., Chung, E., Chi, G. F., Ahn, W., Lim, J. E., Hong, H. S., Kim, D. W., Choi, H., Kim, J. and Son, Y. (2012) Substance P induces M2-type macrophages after spinal cord injury. Neuroreport 23, 786-792. https://doi.org/10.1097/WNR.0b013e3283572206
  12. Jiang, M. H., Lim, J. E., Chi, G. F., Ahn, W., Zhang, M., Chung, E. and Son Y. (2013) Substance P reduces apoptotic cell death possibly by modulating the immune response at the early stage after spinal cord injury. Neuroreport 24, 846-851. https://doi.org/10.1097/WNR.0b013e3283650e3d
  13. Kanai, Y., Nakazato, E., Fujiuchi, A., Hara, T. and Imai, A. (2005) Involvement of an increased spinal TRPV1 sensitization through its up-regulation in mechanical allodynia of CCI rats. Neuropharmacology 49, 977-984. https://doi.org/10.1016/j.neuropharm.2005.05.003
  14. Kim, K. J., Yoon, Y. W. and Chung, J. M. (1997) Comparison of three rodent neuropathic pain models. Exp. Brain Res. 113, 200-206. https://doi.org/10.1007/BF02450318
  15. Komatsu, T., Sasaki, M., Sanai, K., Kuwahata, H., Sakurada, C., Tsuzuki, M., Iwata, Y., Sakurada, S. and Sakurada, T. (2009) Intrathecal substance P auguments morphine-induced antinociception: possible relevance in the production of substance P N-terminal fragments. Peptides 30, 1689-1696. https://doi.org/10.1016/j.peptides.2009.06.002
  16. Komatsu, T., Mizoguchi, H., Sasaki, M., Sakurada, C., Tsuzuki, M., Sakurada, S. and Sakurada, T. (2011) Inhibition of ERK phosphorylation by substance P N-terminal fragment decreases capsaicin-induced nociceptive response. Neuropharmacology 61, 608-613. https://doi.org/10.1016/j.neuropharm.2011.04.035
  17. Ledeboer, A., Jekich, B. M., Sloane, E. M., Mahoney, J. H., Langer, S. J., Milligan, E. D., Martin, D., Maier, S. F., Johnson, K. W., Leinwand, L. A., Chavez, R. A. and Watkins, L. R. (2007) Intrathecal interleukin-10 gene therapy attenuates paclitaxel-induced mechanical allodynia and proinflammatory cytokine expression in dorsal root ganglia in rats. Brain Behav. Immun. 21, 686-698. https://doi.org/10.1016/j.bbi.2006.10.012
  18. Lee, J. Y., Shin, T. J., Choi, J. M., Seo, K. S., Kim, H. J., Yoon, T. G., Lee, Y. S., Han, H., Chung, H. J., Oh, Y., Jung, S. J. and Shin, K. J. (2013) Antinociceptive curcuminoid, KMS4034, effects on inflammatory and neuropathic pain likely via modulating TRPV1 in mice. Br. J. Anaesth. 111, 667-672. https://doi.org/10.1093/bja/aet176
  19. Lee, M. J., Shin, T. J., Lee, J. E., Choo, H., Koh, H. Y., Chung, H. J., Pae, A. N., Lee, S. C. and Kim, H. J. (2010) KST5468, a new T-type calcium channel antagonist, has an antinociceptive effect on inflammatory and neuropathic pain models. Pharmacol. Biochem. Behav. 97, 198-204. https://doi.org/10.1016/j.pbb.2010.07.018
  20. Lee, W. H., Shin, T. J., Kim, H. J., Lee, J. K., Suh, H. W., Lee, S. C. and Seo, K. (2011) Intrathecal administration of botulinum neurotoxin type A attenuates formalin-induced nociceptive responses in mice. Anesth. Analg. 112, 228-235. https://doi.org/10.1213/ANE.0b013e3181ffa1d7
  21. Li, W. W., Guo, T. Z., Liang, D. Y., Sun, Y., Kingery, W. S. and Clark J. D. (2012) Substance P signaling controls mast cell activation, degranulation, and nociceptive sensitization in a rat fracture model of complex regional pain syndrome. Anesthesiology 116, 882-895. https://doi.org/10.1097/ALN.0b013e31824bb303
  22. Lin, C. C., Chen, W. N., Chen, C. J., Lin, Y. W., Zimmer, A. and Chen, C. C. (2012) An antinociceptive role for substance P in acid-induced chronic muscle pain. Proc. Natl. Acad. Sci. U.S.A. 109, E76-E83. https://doi.org/10.1073/pnas.1108903108
  23. Ma, W. and Quirion, R. (2005) The ERK/MAP pathway, as a target for the treatment of neuropathic pain. Expert Opin. Ther. Targets 9, 699-713. https://doi.org/10.1517/14728222.9.4.699
  24. Mika, J., Zychowska, M., Popiolek-Barczyk, K., Rojewska, E. and Przewlocka, B. (2013) Importance of glial activation in neuropathic pain. Eur. J. Pharmacol. 716, 106-119. https://doi.org/10.1016/j.ejphar.2013.01.072
  25. Milligan, E. D. and Watkins, L. R. (2009) Pathological and protective roles of glia in chronic pain. Nat. Rev. Neurosci. 10, 23-36. https://doi.org/10.1038/nrn2533
  26. Muto, Y., Sakai, A., Sakamoto, A. and Suzuki, H. (2012) Activation of NK1 receptors in the locus coeruleus induces analgesia through noradrenergic-mediated descending inhibition in a rat model of neuropathic pain. Br. J. Pharmacol. 166, 1047-1057. https://doi.org/10.1111/j.1476-5381.2011.01820.x
  27. Nakayama, T., Naono, R., Ikeda, T. and Nishimori, T. (2010) NMDA and AMPA receptors contribute to the maintenance of substance P-induced thermal hyperalgesia. Neurosci. Res. 67, 18-24. https://doi.org/10.1016/j.neures.2010.01.006
  28. Nichols, M. L., Allen, B. J., Rogers, S. D., Ghilardi, J. R., Honore, P., Luger, N. M., Pinke, M. P., Li, J., Lappi, D. A., Simone, D. A. and Mantyh, P. W. (1999) Transmission of chronic nociception by spinal neurons expressing the substance P receptor. Science 286, 1558-1561. https://doi.org/10.1126/science.286.5444.1558
  29. Pailleux, F., Lemoine, J. and Beaudry, F. (2013) Investigation of the metabolic biotransformation of substance P in liver microsomes by liquid chromatography quadrupole ion trap mass spectrometry. Biomed. Chromatogr. 27, 39-47. https://doi.org/10.1002/bmc.2746
  30. Parenti, C., Arico, G., Ronsisvalle, G. and Scoto, G. M. (2012) Supraspinal injection of Substance P attenuates allodynia and hyperalgesia in a rat model of inflammatory pain. Peptides 34, 412-418. https://doi.org/10.1016/j.peptides.2012.01.016
  31. Parris, W. C. V., Kambam, J. R., Naukam, R. J. and Rama Sastry, B. V. (1990) Immunoreactive substance P is decreased in saliva of patients with chronic back pain syndromes. Anesth. Analg. 70, 63-67. https://doi.org/10.1213/00000539-199002001-00063
  32. Sahbaie, P., Shi, X., Guo, T. Z., Qiao, Y., Yeomans, D. C., Kingery, W. S. and Clark, J. D. (2009) Role of substance P signaling in enhanced nociceptive sensitization and local cytokine production after incision. Pain 145, 341-349. https://doi.org/10.1016/j.pain.2009.06.037
  33. Shibata, K., Sugawara, T., Fujishita, K., Shinozaki, Y., Matsukawa, T., Suzuki, T. and Koizumi, S. (2011) The astrocyte-targeted therapy by Bushi for the neuropathic pain in mice. PLoS ONE 6, e23510. https://doi.org/10.1371/journal.pone.0023510
  34. Shimizu, K., Guo, W., Wang, H., Zou, S., LaGraize, S. C., Iwata, K., Wei, F., Dubner, R. and Ren, K. (2009) Differential involvement of trigeminal transition zone and laminated subnucleus caudalis in orofacial deep and cutaneous hyperalgesia: the effects of interleukin-10 and glial inhibitors. Mol. Pain 5, 75.
  35. Takeda, K., Sawamura, S., Sekiyama, H., Tamai, H. and Hanaoka, K. (2004) Effect of methylprednisolone on neuropathic pain and spinal glial activation in rats. Anesthesiology 100, 1249-1257. https://doi.org/10.1097/00000542-200405000-00029
  36. Traub, R. J. (1996) The spinal contribution of substance P to the generation and maintenance of inflammatory hyperalgesia in the rat. Pain 67, 151-161. https://doi.org/10.1016/0304-3959(96)03076-X
  37. Vissers, K. C., Geenen, F., Biermans, R. and Meert, T. F. (2006) Pharmacological correlation between the formalin test and the neuropathic pain behavior in different species with chronic constriction injury. Pharmacol. Biochem. Behav. 84, 479-486. https://doi.org/10.1016/j.pbb.2006.06.011
  38. Wang, L. H., Zhou, S. X., Li, R. C., Zheng, L. R., Zhu, J. H., Hu, S. J. and Sun, Y. L. (2012) Serum levels of calcitonin gene-related peptide and substance P are decreased in patients with diabetes mellitus and coronary artery disease. J. Int. Med. Res. 40, 134-140. https://doi.org/10.1177/147323001204000114

Cited by

  1. The neuropathic pain: An overview of the current treatment and future therapeutic approaches vol.33, pp.None, 2017, https://doi.org/10.1177/2058738419838383
  2. Ion Channels Involved in Substance P-Mediated Nociception and Antinociception vol.20, pp.7, 2017, https://doi.org/10.3390/ijms20071596
  3. Long Noncoding RNA H19 Induces Neuropathic Pain by Upregulating Cyclin-Dependent Kinase 5-Mediated Phosphorylation of cAMP Response Element Binding Protein vol.13, pp.None, 2017, https://doi.org/10.2147/jpr.s240273
  4. Neurokinin receptor mechanisms in forebrain medial septum modulate nociception in the formalin model of inflammatory pain vol.11, pp.1, 2017, https://doi.org/10.1038/s41598-021-03661-6